Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma
Table 4
Median time to progression.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Median time to progression.